← All indications
Recurrence
The return of a sign, symptom, or disease after a remission.
Subtype terms (2)
More specific conditions that are subtypes of Recurrence in the MeSH hierarchy.
- Reinfection
1 drug experimental
- Symptom Flare Up
3 drugs experimental
Drugs by status
Phase 4 trials (16)
Phase 3 trials (51)
- 131i-lipiodol
- decitabine
- methylprednisolone
- Ga 68 PSMA-11
- abemaciclib
- acetylcysteine
- sorafenib
- busulfan
- irinotecan
- gemcitabine
- fluorouracil
- leuprolide
- goserelin
- mesalamine
- amantadine
- iodine
- lenvatinib
- leucovorin
- ocrelizumab
- flecainide
- ranolazine
- exemestane
- ribavirin
- semustine
- cyclosporine
- acetylsalicylic acid
- mycophenolate
- cyclophosphamide
- temozolomide
- bevacizumab
- +21 more
Phase 2 trials (48)
- azacitidine
- vitamin d3
- olaparib
- venetoclax
- carfilzomib
- lenalidomide
- durvalumab
- fulvestrant
- tacrolimus
- naltrexone
- lapatinib
- calcium
- idelalisib
- interferon alpha-5
- apalutamide
- pembrolizumab
- ribociclib
- ibrutinib
- peripheral blood lymphocytes
- carboplatin
- Isatuximab
- Rezvilutamide
- allogeneic lymphocytes
- topotecan
- bortezomib
- cd19 car-t cells
- carvedilol
- cd22 car-t cells
- human placental derived stem cells
- autologous mesenchymal stem cells
- +18 more
Phase 1 trials (23)
- cladribine
- betaine
- brentuximab vedotin
- ketamine
- epacadostat
- abeotaxane
- vcn-01
- bupropion
- tgfbeta resistant lmp-specific ctls
- autologous mononuclear stem cell
- midazolam
- pngvl4a-sig/e7
- hsp70 dna vaccine
- dihydroxyacetone
- lv-nyeso tcr /sr39tk pbsc
- rv-nyeso tcr pbmc
- odm-203
- ziftomenib
- amg 509
- lp-108
- rd13-01
- ab-1015
- ic9-car.b7-h3 t cells
Organizations
Organization Involved with Phase 4 Indications (113)
- Second Military Medical University
- University of Oxford
- National Taiwan University
- Dermatrials Research
- Merck Serono
- University of Sao Paulo
- Shandong Province Qianfoshan Hospital
- Alexandria University
- University of Western Australia
- Xiamen Traditional Chinese Medicine Co., Ltd.
- Hospital do Rim e Hipertensão
- G.Gennimatas General Hospital
- Kaohsiung Medical University
- University of Minnesota
- Badalona Hospital Germans Trias i Pujol
- Merck
- Johns Hopkins University
- The University of Hong Kong
- Wyeth
- Government of Korea
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Peking University
- Novartis
- Perrigo
- University of Turin
- First People's Hospital of Hangzhou
- The University of Texas, Dallas
- Tainan Municipal Hospital
- Chiayi Christian Hospital
- Johnson and Johnson
- +83 more
Organization Involved with Phase 3 Indications (199)
- Progenics
- ABX advanced biochemical compounds GmbH
- Kowa
- Universidad de Cordoba
- Translational Research Informatics Center, Kobe, Hyogo, Japan
- University of Rennes
- Universidad Complutense de Madrid
- University of Duisburg-Essen
- Radboud University
- Univerisiti Sains Malaysia
- University of Salamanca
- Genentech
- National Cancer Institute, France
- Serum Institute of India Pvt. Ltd.
- Galena Biopharma, Inc.
- Institut Gustave Roussy
- Innovate UK
- Humboldt University
- Centre Hospitalier de Saint-Brieuc
- Schering-Plough
- Fonds NutsOhra
- Centre Leon Berard
- Gateway for Cancer Research
- Parexel
- Government of France
- Fundación Althaia Manresa
- Katholieke Universiteit Leuven
- Amercian Australian Asian Adrenal Alliance (A5)
- Mallinckrodt
- International Myeloma Foundation (IMF)
- +169 more
Organization Involved with Phase 2 Indications (154)
- Gilead Sciences
- Cumberland Pharmaceuticals
- UroGen Pharma
- Shanghai Xuhui District Central Hospital
- Theragnostics Ltd
- Morphotek
- Millennium Pharmaceuticals
- Peter MacCallum Cancer Centre
- Cedars-Sinai Medical Center
- Changhai Hospital
- Jilin University
- Crohn's and Colitis Foundation
- Institut Bergonié
- Sequel Pharmaceuticals
- University of North Carolina at Chapel Hill
- Myrexis Inc.
- Cardiome Pharma
- Boston University
- Saarland University
- Stony Brook University
- Hebrew University
- Ludwig Institute for Cancer Research
- Stanford University
- University of Bordeaux
- Yeshiva University
- Oncovir, Inc.
- Inovio Pharmaceuticals
- Kyowa Hakko Kirin
- University of Leipzig
- International organization for the study of inflammatory bowel disease (IOIBD)
- +124 more
Organization Involved with Phase 1 Indications (54)
- SPARC
- Five Eleven Pharma, Inc.
- Ohio State University
- Nippon Shinyaku Co Ltd
- Institut Català d'Oncologia
- Inatherys
- Dunkin Donuts
- FWO, Belgium
- GeneScience Pharmaceuticals Co., Ltd.
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Brain & Spine Surgeons of New York
- Trinity College Dublin
- University of New Mexico
- Hebei Senlang Biotechnology Inc., Ltd.
- Miller Children's & Women's Hospital Long Beach
- City of Hope National Medical Center
- Sheffield Hallam University
- Ghent University
- Newave Pharmaceutical Inc
- Eye Pharma
- Pharm-Olam International
- French Innovative Leukemia Organisation
- Aichi Medical University
- Vaximm GmbH
- Agennix
- China Academy of Chinese Medical Sciences
- University of California, Irvine
- University of Franche-Comté
- United States Army
- University of Bonn
- +24 more
Organization Involved with Other Experimental Indications (39)
- Istituto Nazionale per lo Studio e la Cura dei Tumori
- Blood Center of Wisconsin
- Tanner Foundation for Multiple Sclerosis
- Xinjiang Medical University
- Instituto do Cancer do Estado de São Paulo
- Clinical Directors Network
- Alice Brenaa Foundation
- iReportoire Inc
- University of Louisville
- Guangxi Medical University
- Emek Medical Center
- Hillel Yaffe Medical Center
- Kaiser Permanente
- Ontario Institute for Cancer Research
- Tanner Center for MS
- Xiamen University
- Isfahan University
- Hede Nielsen Foundation
- University of Western Ontario
- University of Burgundy
- Shengjing Hospital
- Daegu Catholic University
- Mansoura University
- Albert Schweitzer Hospital
- Shanghai University of Traditional Chinese Medicine
- Government of Thailand
- Urology and Nephrology Center
- King Faisal Specialist Hospital
- University of Southern Denmark
- Holles Laboratories, Inc.
- +9 more